-
1 Comment
GN Store Nord A/S is currently in a long term uptrend where the price is trading 16.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
GN Store Nord A/S's total revenue rose by 10.9% to $4B since the same quarter in the previous year.
Its net income has dropped by 5.2% to $527M since the same quarter in the previous year.
Finally, its free cash flow grew by 288.7% to $1B since the same quarter in the previous year.
Based on the above factors, GN Store Nord A/S gets an overall score of 4/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | DK0010272632 |
Sector | Healthcare |
Industry | Medical Devices |
PE Ratio | 13.81 |
---|---|
Target Price | 575 |
Market Cap | 2B |
Beta | 1.61 |
Dividend Yield | None |
GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, rest of Europe, North America, and internationally. The company operates through Hearing, Enterprise, and Gaming and Consumer segments. The Hearing segment produces and sells hearing instruments and products. The Enterprise segment supplies audio and video devices for professional uses. The Gaming and Consumer segment produces gaming devices, peripherals, and consumer audio devices. It offers its products under the ReSound, Jabra, Beltone, Interton, Danavox, BlueParrott, FalCom, and SteelSeries brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GNN.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025